Home » Topics » Conferences

Conferences
RSS

Latvian researchers discover potential new treatment for heart failure

Aug. 10, 1998

Y-128 is effective in improving diabetic peripheral nerve disorder

July 30, 1998

KRH-594: profile of a new angiotensin II receptor antagonist

July 29, 1998

Mechanism of action, anxiolytic and anticonvulsant activity of AWD-131-138

July 28, 1998

Effects of RGH-2716 on neurotransmitter release and cerebral energy metabolism

July 28, 1998

AIT-082: a new neuroregenerative compound

July 28, 1998

Jenapharm describes scavestrogens, a novel class of nonfeminizing estrogens

July 23, 1998

Preclinical results point to anxiolytic efficacy for Yoshitomi benzodiazepine

July 22, 1998

Vigabatrin is effective for treating alcohol withdrawal syndrome

July 22, 1998

GV-150013 has dual therapeutic potential in treating alcoholism and sleep disorders

July 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...